Gelonghui, April 22丨According to the latest equity disclosure data of the Stock Exchange, on April 19, 2024, China Biopharmaceutical (01177.HK) was granted an increase of 2.5 million shares at an average price of HK$2.3223 per share on the market, involving approximately HK$5.8058 million.

After the increase in holdings, Xie Qirun's latest shareholding was 4 million shares, and the shareholding ratio increased from 0.01% to 0.02%.